Clinical Trial Update: Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety and effectiveness study of autologous natural killer and natural killer T cell therapy for multiple cancers is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioma
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Prostate Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Autologous natural killer and natural killer T cell therapy

Snippet

Sponsor: Envita Medical Center, Inc. | Conditions: Breast Cancer, Glioma | Phase 1 | Status: SUSPENDED